<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free survival (C) and distant metastasis-free survival rates (D) were compared in the subgroup of NPC patients with chronic HBV infection. Hazards ratios (HRs) were calculated using the unadjusted Cox proportional hazards model. P values were calculated using the unadjusted log-rank test.</p
<p>Abbreviation: No., number of patients; MST, median survival time; HR, hazard ratio; CI, confidenc...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>Kaplan-Meier cumulative survival curve comparing subjects with plasma free Hb>50 mg/dL or<50 mg/d...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>The 780 NHL patients who received at least 3 courses of chemotherapy were followed-up, and the fo...
<p>(A) Survival probability did not significantly differ based on HBV infection (<i>p</i> = 0.37). (...
<p>The patients were divided into two groups according to their sMICA concentration (high: >5 pg/ml ...
<p>Dashed line represented the high-risk group (PI ≥ 3.91) and plain line represented the low-risk g...
<p>Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p>Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...
<p>The follow-up data from 780 NHL patients who received at least 3 courses of chemotherapy were ill...
<p>Kaplan-Meier cumulative survival curve comparing subjects with plasma free Hb>50 mg/dL or<50 mg/d...
<p>Abbreviation: No., number of patients; MST, median survival time; HR, hazard ratio; CI, confidenc...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>Kaplan-Meier cumulative survival curve comparing subjects with plasma free Hb>50 mg/dL or<50 mg/d...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free surviv...
<p>The 780 NHL patients who received at least 3 courses of chemotherapy were followed-up, and the fo...
<p>(A) Survival probability did not significantly differ based on HBV infection (<i>p</i> = 0.37). (...
<p>The patients were divided into two groups according to their sMICA concentration (high: >5 pg/ml ...
<p>Dashed line represented the high-risk group (PI ≥ 3.91) and plain line represented the low-risk g...
<p>Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p>Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...
<p>The follow-up data from 780 NHL patients who received at least 3 courses of chemotherapy were ill...
<p>Kaplan-Meier cumulative survival curve comparing subjects with plasma free Hb>50 mg/dL or<50 mg/d...
<p>Abbreviation: No., number of patients; MST, median survival time; HR, hazard ratio; CI, confidenc...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>Kaplan-Meier cumulative survival curve comparing subjects with plasma free Hb>50 mg/dL or<50 mg/d...